oxyphenbutazone and caffeine

oxyphenbutazone has been researched along with caffeine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Moss, MS1
Hsiu, HC; Shih, TB; Wang, KT1
Holmes, MJ; Koh, HL; Lau, AJ; Woo, SO1
EYSOLD, R1

Reviews

1 review(s) available for oxyphenbutazone and caffeine

ArticleYear
A review of drug "clearance times" in racehorses.
    Equine veterinary journal, 1977, Volume: 9, Issue:2

    Topics: Acepromazine; Amphetamine; Animals; Caffeine; Ephedrine; Epinephrine; Glucocorticoids; Horses; Norepinephrine; Oxyphenbutazone; Pentobarbital; Pharmaceutical Preparations; Phenylbutazone

1977

Other Studies

6 other study(ies) available for oxyphenbutazone and caffeine

ArticleYear
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Polyamide layer chromatography of some antipyretics.
    Journal of chromatography, 1969, May-20, Volume: 41, Issue:3

    Topics: Acetanilides; Amides; Aminopyrine; Analgesics; Antipyrine; Aspirin; Caffeine; Chromatography, Thin Layer; Indomethacin; Oxyphenbutazone; Phenacetin; Salicylates

1969
Analysis of adulterants in a traditional herbal medicinal product using liquid chromatography-mass spectrometry-mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2003, Feb-26, Volume: 31, Issue:2

    Topics: Caffeine; Chromatography, Liquid; Drug Contamination; Herbal Medicine; Mass Spectrometry; Oxyphenbutazone; Phenylbutazone; Sensitivity and Specificity

2003
[GENESIS, CLASSIFICATION AND THERAPY OF LOSS OF CONSCIOUSNESS].
    Monatsschrift fur Kinderheilkunde, 1963, Volume: 111

    Topics: Caffeine; Child; Classification; Electroencephalography; Epilepsy; Epilepsy, Absence; Humans; Oxyphenbutazone; Phenobarbital; Phenytoin; Physiology; Pyrrolidinones; Unconsciousness

1963